GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Adventa Bhd (XKLS:7191) » Definitions » EV-to-EBITDA

Adventa Bhd (XKLS:7191) EV-to-EBITDA : -12.80 (As of May. 17, 2024)


View and export this data going back to 2004. Start your Free Trial

What is Adventa Bhd EV-to-EBITDA?

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Adventa Bhd's enterprise value is RM99.57 Mil. Adventa Bhd's EBITDA for the trailing twelve months (TTM) ended in Mar. 2024 was RM-7.78 Mil. Therefore, Adventa Bhd's EV-to-EBITDA for today is -12.80.

The historical rank and industry rank for Adventa Bhd's EV-to-EBITDA or its related term are showing as below:

XKLS:7191' s EV-to-EBITDA Range Over the Past 10 Years
Min: -77.38   Med: 12.41   Max: 64.1
Current: -12.8

During the past 13 years, the highest EV-to-EBITDA of Adventa Bhd was 64.10. The lowest was -77.38. And the median was 12.41.

XKLS:7191's EV-to-EBITDA is ranked worse than
100% of 488 companies
in the Medical Devices & Instruments industry
Industry Median: 16.14 vs XKLS:7191: -12.80

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-05-17), Adventa Bhd's stock price is RM0.375. Adventa Bhd's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 was RM-0.048. Therefore, Adventa Bhd's PE Ratio for today is At Loss.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.


Adventa Bhd EV-to-EBITDA Historical Data

The historical data trend for Adventa Bhd's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Adventa Bhd EV-to-EBITDA Chart

Adventa Bhd Annual Data
Trend Oct13 Oct14 Oct15 Oct16 Oct17 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-EBITDA
Get a 7-Day Free Trial Premium Member Only Premium Member Only -6.45 28.12 17.10 -26.16 -9.66

Adventa Bhd Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EV-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -16.73 -10.31 -8.76 -9.66 -9.07

Competitive Comparison of Adventa Bhd's EV-to-EBITDA

For the Medical Instruments & Supplies subindustry, Adventa Bhd's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Adventa Bhd's EV-to-EBITDA Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Adventa Bhd's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Adventa Bhd's EV-to-EBITDA falls into.



Adventa Bhd EV-to-EBITDA Calculation

Adventa Bhd's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=99.566/-7.781
=-12.80

Adventa Bhd's current Enterprise Value is RM99.57 Mil.
Adventa Bhd's EBITDA for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was RM-7.78 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Adventa Bhd  (XKLS:7191) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Adventa Bhd's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=0.375/-0.048
=At Loss

Adventa Bhd's share price for today is RM0.375.
Adventa Bhd's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was RM-0.048.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?


Adventa Bhd EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Adventa Bhd's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Adventa Bhd (XKLS:7191) Business Description

Traded in Other Exchanges
N/A
Address
No. 21, Jalan Tandang 51/205A, Seksyen 51, Petaling Jaya, SGR, MYS, 46050
Adventa Bhd is engaged in the business of medical services and related supplies manufacturing. The company's segments include Healthcare Business, Warehousing provider, and Corporate. It generates maximum revenue from the Healthcare Business segment. The healthcare business segment comprises the supply of healthcare and related products and services to hospitals, healthcare centres, and pharmacies. Previously, it also included the renal dialysis business which are both for home and centre-based treatments, serving both the domestic and export markets. Geographically, it derives a majority of revenue from Malaysia.

Adventa Bhd (XKLS:7191) Headlines

No Headlines